| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date | Match? |
|---|
| Liver metastases of intrahepatic cholangiocarcinoma: implications for a potential new staging system | [1]Angela Lamarca, [2]Alvaro Santos-Laso, [3]Kirsten Utpatel, [4]Adelaida La Casta, [5]Simone Stock, [6]Alejandro Forner, [7]Jorge Adeva, [8]Trine Folseraas, [9]Luca Fabris, [10]Rocio I. Macias, [11]Marcin Krawczyk, [12]Marek Krawczyk, [13]Vincenzo Cardinale, [14]Chiara Braconi, [15]Domenico Alvaro, [16]Matthias Evert, [17]Jesus M Banales, [18]Juan W Valle, [19]European Network for the Study of Cholangiocarcinoma (ENS-CCA) [Full author list] | Hepatology [missing] | DOI: 10.1002/HEP.31598 [ORCID]
PubMed: 33073396 [ORCID]
| intrahepatic cholangiocarcinoma [missing] | 2020-10-18 | |
| Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study | [1]Ghassan K Abou-Alfa, [2]Teresa Macarulla, [3]Milind M Javle, [4]Robin K Kelley, [5]Sam J Lubner, [6]Jorge Adeva, [7]James M Cleary, [8]Daniel V Catenacci, [9]Mitesh J Borad, [10]John Bridgewater, ... [Full author list] | Lancet Oncology Commission [missing] | DOI: 10.1016/S1470-2045(20)30157-1 [ORCID]
PubMed: 32416072 [ORCID]
| cholangiocarcinoma [missing]; placebo [missing] | 2020-05-13 | Jorge Adeva (Q92501712; 2 items)
|
| Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study | [1]Ana Fernández, [2]Mercedes Salgado, [3]Adelaida García, [4]Elvira Buxò, [5]Ruth Vera, [6]Jorge Adeva, [7]Paula Jiménez-Fonseca, [8]Guillermo Quintero, [9]Cristina Llorca, [10]Mamen Cañabate, ... [Full author list] | BMC Cancer [missing] | DOI: 10.1186/S12885-018-5101-3 [ORCID]
PubMed: 30497432 [ORCID]
| pancreatic cancer [missing] | 2018-11-29 | |